The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
ICR hails ‘momentous’ recommendation of olaparib for breast and prostate cancer
The Institute of Cancer Research, London, has hailed the ‘life-changing’ decision by NICE to recommend…